The company anticipates 2025 revenue to be in the range of $58.0 billion to $61.0 billion, growth of 32% at the midpoint compared to expected 2024 revenue ...

Precigen, Inc. , a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced Helen Sabzevari, PhD, President and ...

The lawmakers also say that a Cures 2.1 push should include an update to the government’s clinical trial website to enable ... data submitted by each pharmaceutical company and explain how ...

Oncology Cancer Drugs Market With a projected ... Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold ...

These generic granules are equivalent to Vertex Pharmaceuticals' 'Kalydeco' oral granules in the same strengths.

Eli Lilly has launched a new website-based access ... diabetes and migraine drugs, respectively, via telehealth providers 9amHealth and Cove. According to the company, it allows “consistent ...

A longtime pharmaceutical executive laments the woeful state of the industry and calls for new leadership to win back public ...

Natural Gas Stocks Hit Buy Points. Williams Cos powered up 3.4% and broke out of a cup-with-handle base with a 57.25 buy point. The natural gas pipeline stock ...

Eli Lilly unexpectedly lowered its full-year 2024 guidance. The miss appears to stem from a lack of the typical December ...

Eli Lilly said on Monday it has sued two medical spas for selling unapproved products claiming to contain tirzepatide, the ...